/Lists

Healthtech Late Stage Investors & VC Firms

494 firms in this list, with a median first check of $1M. 98 of them lead rounds. Generated from verified public data and updated continuously.

Celtic House Asia Partners
TorontoPre-Seed–Late Stage
4 people
Cohen Circle
New YorkPre-Seed–Late Stage
13 people
Rock Springs Capital
BaltimoreLate Stage
13 people
Livingbridge
LondonGrowth–Late Stage
18 people
BrightEdge
AtlantaPre-Seed–Late Stage
15 people
Darwin Venture Management
TaipeiSeed–Late Stage$1M – $5M
19 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Pharos Capital Group
DallasGrowth–Late Stage$25M – $50M
19 people
NovaCapital
Seed–Late Stage
9 people
Heliad AG
Frankfurt am MainPre-Seed–Late Stage$5.4M – $16.2M
14 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
19 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Gilead Sciences
Foster CitySeries B–Late Stage
19 people
Quadrille Capital
ParisSeed–Late Stage
15 people
Scottish Mortgage Investment Trust PLC
EdinburghSeed–Late Stage
18 people
Owl Rock Capital
New YorkGrowth–Late Stage
14 people
OWW Capital Partners Pte. Ltd.
SingaporeSeed–Late Stage$500K – $10M
9 people
Minerva Growth Partners
TokyoGrowth–Late Stage$6.7M – $20M
14 people
Bridge Bank
San FranciscoSeed–Late Stage
16 people
Excel Venture Management
BostonSeries A–Late Stage$1M – $5M
7 people
Bonitás Ventures
BudapestGrowth–Late Stage$540K – $4.3M
18 people
Third Eye Capital
TorontoSeed–Late Stage
21 people
Peak State Ventures
New YorkPre-Seed–Late Stage$100K – $15M
1 person
Channel 4 Ventures
LondonSeed–Late Stage$1.3M – $6.3M
5 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.